Table 1 Clinical characteristics of patients with Stenotrophomonas maltophilia bloodstream infections according to the overall survival status

Age

49 (22–65)

48 (18–78)

0.416

Male

6 (54.5%)

12 (60.0%)

0.999

Underlying disease

  Myeloid malignancies

6 (54.5%)

15 (75.0%)

0.453

  Lymphoid malignancies

3 (27.3%)

3 (15%)

  Others

2 (18.2%)

2 (10.0%)

Treatment

  Chemotherapy

8 (72.7%)

9 (45.0%)

0.089

  Stem cell transplantation

3 (27.3%)

4 (20.0%)

  Palliative care

0 (0.0%)

7 (35.0%)

Hospital stay, days

26 (0–48)

23.5 (0–120)

0.119

Duration of neutropenia^a, days

3 (0–36)

40 (1–135)

0.016

Neutropenia at the onset of BSI (<500/mm³)

7 (63.6%)

19 (95.0%)

0.042

Severe neutropenia at the onset of BSI (<100/mm³)

6 (54.5%)

17 (85.0%)

0.095

SAPS II

30 (26–49)

38.5 (23–70)

0.030

Source of infection

  Pneumonia

0 (0.0%)

13 (65.0%)

0.001

  Catheter

6 (54.5%)

0 (0.0%)

0.001

  Primary

3 (27.3%)

4 (20.0%)

0.999

  SSTI

1 (9.1%)

3 (15.0%)

0.999

  Abdomen

1 (9.1%)

0 (0.0%)

0.355

Polymicrobial BSI

3 (27.3%)

7 (35.0%)

0.999

Shock

2 (18.2%)

12 (60.0%)

0.057